auto

Jaguar car brand to go fully electric from 2025


Globe Newswire

Global Intermittent Catheters Industry

Global Intermittent Catheters Market to Reach $3. 4 Billion by 2027. Amid the COVID-19 crisis, the global market for Intermittent Catheters estimated at US$2. 1 Billion in the year 2020, is projected to reach a revised size of US$3.New York, Feb. 15, 2021 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Intermittent Catheters Industry” – https://www.reportlinker.com/p05957153/?utm_source=GNW 4 Billion by 2027, growing at a CAGR of 7.3% over the analysis period 2020-2027. Urinary Incontinence, one of the segments analyzed in the report, is projected to record a 8.1% CAGR and reach US$1.5 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Spinal Cord Injuries segment is readjusted to a revised 7.3% CAGR for the next 7-year period. The U.S. Market is Estimated at $620 Million, While China is Forecast to Grow at 6.8% CAGR The Intermittent Catheters market in the U.S. is estimated at US$620 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$599.4 Million by the year 2027 trailing a CAGR of 6.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 6.8% and 5.9% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 5.9% CAGR. General Surgery Segment to Record 6.5% CAGR In the global General Surgery segment, USA, Canada, Japan, China and Europe will drive the 6.5% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$350.2 Million in the year 2020 will reach a projected size of US$545.9 Million by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$395.4 Million by the year 2027.We bring years of research experience to this 5th edition of our report. The 227-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed. Competitors identified in this market include, among others, Adapta Medical, Inc.B. Braun Melsungen AGBecton, Dickinson and CompanyColoplast A/SCure Medical LLCHollister, Inc.Medical Technologies of Georgia, Inc.Pennine Healthcare Ltd.Teleflex, Inc. Read the full report: https://www.reportlinker.com/p05957153/?utm_source=GNW I. INTRODUCTION, METHODOLOGY & REPORT SCOPE II. EXECUTIVE SUMMARY 1. MARKET OVERVIEW Global Competitor Market Shares Intermittent Catheters Competitor Market Share Scenario Worldwide (in %): 2019 & 2025 Impact of Covid-19 and a Looming Global Recession 2. FOCUS ON SELECT PLAYERS 3. MARKET TRENDS & DRIVERS 4. GLOBAL MARKET PERSPECTIVE Table 1: World Current & Future Analysis for Intermittent Catheters by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 2: World Historic Review for Intermittent Catheters by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 3: World 15-Year Perspective for Intermittent Catheters by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027 Table 4: World Current & Future Analysis for Urinary Incontinence by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 5: World Historic Review for Urinary Incontinence by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 6: World 15-Year Perspective for Urinary Incontinence by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 7: World Current & Future Analysis for Spinal Cord Injuries by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 8: World Historic Review for Spinal Cord Injuries by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 9: World 15-Year Perspective for Spinal Cord Injuries by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 10: World Current & Future Analysis for General Surgery by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 11: World Historic Review for General Surgery by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 12: World 15-Year Perspective for General Surgery by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 13: World Current & Future Analysis for Other Indications by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 14: World Historic Review for Other Indications by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 15: World 15-Year Perspective for Other Indications by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 16: World Current & Future Analysis for Female Length Catheters by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 17: World Historic Review for Female Length Catheters by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 18: World 15-Year Perspective for Female Length Catheters by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 19: World Current & Future Analysis for Male Length Catheters by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 20: World Historic Review for Male Length Catheters by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 21: World 15-Year Perspective for Male Length Catheters by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 22: World Current & Future Analysis for Kid Length Catheters by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 23: World Historic Review for Kid Length Catheters by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 24: World 15-Year Perspective for Kid Length Catheters by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 25: World Current & Future Analysis for Hospitals by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 26: World Historic Review for Hospitals by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 27: World 15-Year Perspective for Hospitals by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 28: World Current & Future Analysis for Ambulatory Surgery Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 29: World Historic Review for Ambulatory Surgery Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 30: World 15-Year Perspective for Ambulatory Surgery Centers by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 Table 31: World Current & Future Analysis for Medical Research Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 32: World Historic Review for Medical Research Centers by Geographic Region – USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 33: World 15-Year Perspective for Medical Research Centers by Geographic Region – Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027 III. MARKET ANALYSIS GEOGRAPHIC MARKET ANALYSIS UNITED STATES Market Facts & Figures US Intermittent Catheters Market Share (in %) by Company: 2019 & 2025 Market Analytics Table 34: USA Current & Future Analysis for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 35: USA Historic Review for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 36: USA 15-Year Perspective for Intermittent Catheters by Indication – Percentage Breakdown of Value Sales for Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications for the Years 2012, 2020 & 2027 Table 37: USA Current & Future Analysis for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 38: USA Historic Review for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 39: USA 15-Year Perspective for Intermittent Catheters by Category – Percentage Breakdown of Value Sales for Female Length Catheters, Male Length Catheters and Kid Length Catheters for the Years 2012, 2020 & 2027 Table 40: USA Current & Future Analysis for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 41: USA Historic Review for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 42: USA 15-Year Perspective for Intermittent Catheters by End-Use – Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Medical Research Centers for the Years 2012, 2020 & 2027 CANADA Table 43: Canada Current & Future Analysis for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 44: Canada Historic Review for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 45: Canada 15-Year Perspective for Intermittent Catheters by Indication – Percentage Breakdown of Value Sales for Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications for the Years 2012, 2020 & 2027 Table 46: Canada Current & Future Analysis for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 47: Canada Historic Review for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 48: Canada 15-Year Perspective for Intermittent Catheters by Category – Percentage Breakdown of Value Sales for Female Length Catheters, Male Length Catheters and Kid Length Catheters for the Years 2012, 2020 & 2027 Table 49: Canada Current & Future Analysis for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 50: Canada Historic Review for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 51: Canada 15-Year Perspective for Intermittent Catheters by End-Use – Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Medical Research Centers for the Years 2012, 2020 & 2027 JAPAN Table 52: Japan Current & Future Analysis for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 53: Japan Historic Review for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 54: Japan 15-Year Perspective for Intermittent Catheters by Indication – Percentage Breakdown of Value Sales for Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications for the Years 2012, 2020 & 2027 Table 55: Japan Current & Future Analysis for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 56: Japan Historic Review for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 57: Japan 15-Year Perspective for Intermittent Catheters by Category – Percentage Breakdown of Value Sales for Female Length Catheters, Male Length Catheters and Kid Length Catheters for the Years 2012, 2020 & 2027 Table 58: Japan Current & Future Analysis for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 59: Japan Historic Review for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 60: Japan 15-Year Perspective for Intermittent Catheters by End-Use – Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Medical Research Centers for the Years 2012, 2020 & 2027 CHINA Table 61: China Current & Future Analysis for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 62: China Historic Review for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 63: China 15-Year Perspective for Intermittent Catheters by Indication – Percentage Breakdown of Value Sales for Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications for the Years 2012, 2020 & 2027 Table 64: China Current & Future Analysis for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 65: China Historic Review for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 66: China 15-Year Perspective for Intermittent Catheters by Category – Percentage Breakdown of Value Sales for Female Length Catheters, Male Length Catheters and Kid Length Catheters for the Years 2012, 2020 & 2027 Table 67: China Current & Future Analysis for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 68: China Historic Review for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 69: China 15-Year Perspective for Intermittent Catheters by End-Use – Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Medical Research Centers for the Years 2012, 2020 & 2027 EUROPE Market Facts & Figures European Intermittent Catheters Market: Competitor Market Share Scenario (in %) for 2019 & 2025 Market Analytics Table 70: Europe Current & Future Analysis for Intermittent Catheters by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2020 through 2027 Table 71: Europe Historic Review for Intermittent Catheters by Geographic Region – France, Germany, Italy, UK and Rest of Europe Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 72: Europe 15-Year Perspective for Intermittent Catheters by Geographic Region – Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027 Table 73: Europe Current & Future Analysis for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 74: Europe Historic Review for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 75: Europe 15-Year Perspective for Intermittent Catheters by Indication – Percentage Breakdown of Value Sales for Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications for the Years 2012, 2020 & 2027 Table 76: Europe Current & Future Analysis for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 77: Europe Historic Review for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 78: Europe 15-Year Perspective for Intermittent Catheters by Category – Percentage Breakdown of Value Sales for Female Length Catheters, Male Length Catheters and Kid Length Catheters for the Years 2012, 2020 & 2027 Table 79: Europe Current & Future Analysis for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 80: Europe Historic Review for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 81: Europe 15-Year Perspective for Intermittent Catheters by End-Use – Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Medical Research Centers for the Years 2012, 2020 & 2027 FRANCE Table 82: France Current & Future Analysis for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 83: France Historic Review for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 84: France 15-Year Perspective for Intermittent Catheters by Indication – Percentage Breakdown of Value Sales for Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications for the Years 2012, 2020 & 2027 Table 85: France Current & Future Analysis for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 86: France Historic Review for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 87: France 15-Year Perspective for Intermittent Catheters by Category – Percentage Breakdown of Value Sales for Female Length Catheters, Male Length Catheters and Kid Length Catheters for the Years 2012, 2020 & 2027 Table 88: France Current & Future Analysis for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 89: France Historic Review for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 90: France 15-Year Perspective for Intermittent Catheters by End-Use – Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Medical Research Centers for the Years 2012, 2020 & 2027 GERMANY Table 91: Germany Current & Future Analysis for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 92: Germany Historic Review for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 93: Germany 15-Year Perspective for Intermittent Catheters by Indication – Percentage Breakdown of Value Sales for Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications for the Years 2012, 2020 & 2027 Table 94: Germany Current & Future Analysis for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 95: Germany Historic Review for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 96: Germany 15-Year Perspective for Intermittent Catheters by Category – Percentage Breakdown of Value Sales for Female Length Catheters, Male Length Catheters and Kid Length Catheters for the Years 2012, 2020 & 2027 Table 97: Germany Current & Future Analysis for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 98: Germany Historic Review for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 99: Germany 15-Year Perspective for Intermittent Catheters by End-Use – Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Medical Research Centers for the Years 2012, 2020 & 2027 ITALY Table 100: Italy Current & Future Analysis for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 101: Italy Historic Review for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 102: Italy 15-Year Perspective for Intermittent Catheters by Indication – Percentage Breakdown of Value Sales for Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications for the Years 2012, 2020 & 2027 Table 103: Italy Current & Future Analysis for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 104: Italy Historic Review for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 105: Italy 15-Year Perspective for Intermittent Catheters by Category – Percentage Breakdown of Value Sales for Female Length Catheters, Male Length Catheters and Kid Length Catheters for the Years 2012, 2020 & 2027 Table 106: Italy Current & Future Analysis for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 107: Italy Historic Review for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 108: Italy 15-Year Perspective for Intermittent Catheters by End-Use – Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Medical Research Centers for the Years 2012, 2020 & 2027 UNITED KINGDOM Table 109: UK Current & Future Analysis for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 110: UK Historic Review for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 111: UK 15-Year Perspective for Intermittent Catheters by Indication – Percentage Breakdown of Value Sales for Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications for the Years 2012, 2020 & 2027 Table 112: UK Current & Future Analysis for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 113: UK Historic Review for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 114: UK 15-Year Perspective for Intermittent Catheters by Category – Percentage Breakdown of Value Sales for Female Length Catheters, Male Length Catheters and Kid Length Catheters for the Years 2012, 2020 & 2027 Table 115: UK Current & Future Analysis for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 116: UK Historic Review for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 117: UK 15-Year Perspective for Intermittent Catheters by End-Use – Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Medical Research Centers for the Years 2012, 2020 & 2027 REST OF EUROPE Table 118: Rest of Europe Current & Future Analysis for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 119: Rest of Europe Historic Review for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 120: Rest of Europe 15-Year Perspective for Intermittent Catheters by Indication – Percentage Breakdown of Value Sales for Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications for the Years 2012, 2020 & 2027 Table 121: Rest of Europe Current & Future Analysis for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 122: Rest of Europe Historic Review for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 123: Rest of Europe 15-Year Perspective for Intermittent Catheters by Category – Percentage Breakdown of Value Sales for Female Length Catheters, Male Length Catheters and Kid Length Catheters for the Years 2012, 2020 & 2027 Table 124: Rest of Europe Current & Future Analysis for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 125: Rest of Europe Historic Review for Intermittent Catheters by End-Use – Hospitals, Ambulatory Surgery Centers and Medical Research Centers Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 126: Rest of Europe 15-Year Perspective for Intermittent Catheters by End-Use – Percentage Breakdown of Value Sales for Hospitals, Ambulatory Surgery Centers and Medical Research Centers for the Years 2012, 2020 & 2027 ASIA-PACIFIC Table 127: Asia-Pacific Current & Future Analysis for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 128: Asia-Pacific Historic Review for Intermittent Catheters by Indication – Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications Markets – Independent Analysis of Annual Sales in US$ Thousand for Years 2012 through 2019 Table 129: Asia-Pacific 15-Year Perspective for Intermittent Catheters by Indication – Percentage Breakdown of Value Sales for Urinary Incontinence, Spinal Cord Injuries, General Surgery and Other Indications for the Years 2012, 2020 & 2027 Table 130: Asia-Pacific Current & Future Analysis for Intermittent Catheters by Category – Female Length Catheters, Male Length Catheters and Kid Length Catheters – Independent Analysis of Annual Sales in US$ Thousand for the Years 2020 through 2027 Table 131: Asia-Pacific Historic Review for Intermittent Please contact our Customer Support Center to get the complete Table of ContentsRead the full report: https://www.reportlinker.com/p05957153/?utm_source=GNWAbout ReportlinkerReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.__________________________ CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001



READ SOURCE

Leave a Reply

This website uses cookies. By continuing to use this site, you accept our use of cookies.  Learn more